Atea Pharmaceuticals (AVIR) EPS (Basic) (2019 - 2026)
Atea Pharmaceuticals' (AVIR) quarterly EPS (Basic) came in at -$0.57 in Q1 2026, down 42.57% year-on-year from -$1.0 in Q1 2025, and down 4.21% quarter-over-quarter from -$0.55 in Q4 2025.
Atea Pharmaceuticals (AVIR) EPS (Basic) (2019 - 2026) Analysis & Trends
Atea Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.57 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 42.57% year-over-year to -$0.57 in Q1 2026; TTM through Mar 2026 was -$2.14, a 30.68% decrease from a year earlier, with the FY2025 full-year figure at -$1.94, up 2.76% from the prior year.
- EPS (Basic) eased to -$0.57 in Q1 2026 per AVIR's latest filing, from -$0.55 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.1 in Q3 2022 and bottomed at -$0.75 in Q1 2024.
- The 5-year median for EPS (Basic) is -$0.43 (2023), against an average of -$0.44.
- Biggest YoY gain for EPS (Basic) was 71.54% in 2022; the steepest drop was 2123.49% in 2022.
- Year by year, EPS (Basic) stood at -$0.41 in 2022, then dropped by 13.55% to -$0.47 in 2023, then increased by 15.24% to -$0.4 in 2024, then plunged by 38.31% to -$0.55 in 2025, then fell by 4.21% to -$0.57 in 2026.
- Per Business Quant, the three latest AVIR EPS (Basic) figures stand at -$0.57 (Q1 2026), -$0.55 (Q4 2025), and -$0.53 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Atea Pharmaceuticals | 374.61 Mn | 374.61 Mn | - | -0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.57 |
| Dec 31, 2025 | -0.55 |
| Sep 30, 2025 | -0.53 |
| Jun 30, 2025 | -0.44 |
| Mar 31, 2025 | -0.40 |
| Dec 31, 2024 | -0.40 |
| Sep 30, 2024 | -0.37 |
| Jun 30, 2024 | -0.48 |
| Mar 31, 2024 | -0.75 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.40 |
| Jun 30, 2023 | -0.34 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.41 |
| Sep 30, 2022 | -0.10 |
| Jun 30, 2022 | -0.38 |
| Mar 31, 2022 | -0.51 |
| Dec 31, 2021 | 1.41 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | 0.02 |